Related references
Note: Only part of the references are listed.TREK-1 (K2P2.1) K+ channels are suppressed in patients with atrial fibrillation and heart failure and provide therapeutic targets for rhythm control
Patrick Lugenbiel et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene
Kafa Walweel et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy
Constanze Schmidt et al.
EUROPEAN HEART JOURNAL (2017)
Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels
Rafel Simo-Vicens et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Stabilizing ryanodine receptor gating quiets arrhythmogenic events in human heart failure and atrial fibrillation
Donald M. Bers
HEART RHYTHM (2017)
Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model
Danilo Bacic et al.
HEART RHYTHM (2017)
Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials
Mengqi Gong et al.
HEART RHYTHM (2017)
Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes
Nico Hartmann et al.
HEART RHYTHM (2017)
Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs
Na Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis
Federico Guerra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Ranolazine therapy in drug-refractory ventricular arrhythmias
Antonio Curnis et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2017)
Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics
Nipavan Chiamvimonvat et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Atrial fibrillation: Therapeutic potential of atrial K+ channel blockers
Ursula Ravens et al.
PHARMACOLOGY & THERAPEUTICS (2017)
CaMKII as a target for arrhythmia suppression
Julian Mustroph et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets
Hrayr S. Karagueuzian et al.
FRONTIERS IN PHARMACOLOGY (2017)
Assessment of TRPM7 functions by drug-like small molecules
Vladimir Chubanov et al.
CELL CALCIUM (2017)
Calcium Signaling and Cardiac Arrhythmias
Andrew P. Landstrom et al.
CIRCULATION RESEARCH (2017)
Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk A Pilot Study
David G. Strauss et al.
CIRCULATION (2017)
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokinetics
Scott E. Wolkenberg et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
TRPM4 non-selective cation channel variants in long QT syndrome
Thomas Hof et al.
BMC MEDICAL GENETICS (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Atrial Fibrillation and Ventricular Arrhythmias Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes
Anne M. Gillis
CIRCULATION (2017)
The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis
Jordi Heijman et al.
CARDIOVASCULAR RESEARCH (2016)
Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms
Gerrit Frommeyer et al.
NATURE REVIEWS CARDIOLOGY (2016)
Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia
Zhen Tan et al.
BIOCHEMICAL JOURNAL (2016)
Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts
Xiaowei Zhong et al.
BIOCHEMICAL JOURNAL (2016)
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine
Dmitry O. Koltun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation
John Ford et al.
HEART RHYTHM (2016)
Eleclazine, a new selective cardiac late sodium current inhibitor, confers concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in an intact porcine model
Henrique Fuller et al.
HEART RHYTHM (2016)
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P. Piccini et al.
HEART RHYTHM (2016)
Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials
Pasquale Santangeli et al.
HEART RHYTHM (2016)
Mortality associated to atrial fibrillation still on the rise: United States, 1999 to 2014
Ugo Fedeli et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation
Dingxin Qin et al.
JOURNAL OF CARDIOLOGY (2016)
The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?
Dawood Darbar
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties
Jeff A. Zablocki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift
Hitoshi Uchinoumi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology
Nico Hartmann et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia Reply
Pei-Chi Yang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
Alan J. Williams et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Ranolazine Therapy in Cardiac Arrhythmias
Brian R. Pulford et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2016)
pH-dependent inhibition of K2P3.1 prolongs atrial refractoriness in whole hearts
Mark A. Skarsfeldt et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Mechanisms of Ventricular Arrhythmias: From Molecular Fluctuations to Electrical Turbulence
Zhilin Qu et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
TRPM4 in cardiac electrical activity
Romain Guinamard et al.
CARDIOVASCULAR RESEARCH (2015)
Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade
Martin Aguilar et al.
CIRCULATION (2015)
Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
Constanze Schmidt et al.
CIRCULATION (2015)
The Direct Actions of Flecainide on the Human Cardiac Ryanodine Receptor Keeping Open the Debate on the Mechanism of Action of Local Anesthetics in CPVT
Godfrey L. Smith et al.
CIRCULATION RESEARCH (2015)
Role of Sodium and Calcium Dysregulation in Tachyarrhythmias in Sudden Cardiac Death
Stefan Wagner et al.
CIRCULATION RESEARCH (2015)
Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death
Hugues Abriel et al.
CIRCULATION RESEARCH (2015)
The Spectrum of Epidemiology Underlying Sudden Cardiac Death
Meiso Hayashi et al.
CIRCULATION RESEARCH (2015)
The HARMONY Trial Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism
James A. Reiffel et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Silvia G. Priori et al.
EUROPEAN HEART JOURNAL (2015)
Advances in the pharmacologic treatment of ventricular arrhythmias
J. William Schleifer et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Inhibition of I-Kr potentiates development of atrial-selective I-Na block leading to effective suppression of atrial fibrillation
Alexander Burashnikov et al.
HEART RHYTHM (2015)
Synergistic antiarrhythmic effect of combining inhibition of Ca2+-activated K+ (SK) channels and voltage-gated Na+ channels in an isolated heart model of atrial fibrillation
Jeppe Egedal Kirchhoff et al.
HEART RHYTHM (2015)
Small-conductance Ca2+-activated K+ channels and cardiac arrhythmias
Xiao-Dong Zhang et al.
HEART RHYTHM (2015)
Novel K+ Channel Targets in Atrial Fibrillation Drug Development-Where Are We?
Said El-Haou et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?
Jordi Heijman et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
SK channels and ventricular arrhythmias in heart failure
Po-Cheng Chang et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2015)
Calcium Store Stability as an Antiarrhythmic Endpoint
Antonio Zaza et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea?
Aytug K. Kiper et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Ion Channels in the Heart
Daniel C. Bartos et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Prevalence, Correlates, and Temporal Trends in Antiarrhythmic Drug Use at Discharge After Implantable Cardioverter Defibrillator Placement (from the National Cardiovascular Data Registry [NCDR])
Sandesh Dev et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Ranolazine for the Suppression of Ventricular Arrhythmia: A Case Series
Eric Yeung et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2014)
Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold
Daniel P. Flaherty et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria
Lasse Skibsbye et al.
CARDIOVASCULAR RESEARCH (2014)
Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog
Xiao-Yan Qi et al.
CIRCULATION (2014)
Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression
Jordi Heijman et al.
CIRCULATION RESEARCH (2014)
Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease
Dobromir Dobrev et al.
CIRCULATION RESEARCH (2014)
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Gregory Y. H. Lip et al.
EUROPACE (2014)
Atrial fibrillation: the role of common and rare genetic variants
Morten S. Olesen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
Inhibition of cardiac two-pore-domain K+ (K2p) channels - an emerging antiarrhythmic concept
Constanze Schmidt et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA
Nicole Schmitt et al.
PHYSIOLOGICAL REVIEWS (2014)
Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine
Bernd Nilius et al.
PHARMACOLOGICAL REVIEWS (2014)
Electrical storm: recent pathophysiological insights and therapeutic consequences
Yukiomi Tsuji et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia
Derek S. Steele et al.
CARDIOVASCULAR RESEARCH (2013)
The TRPM4 non-selective cation channel contributes to the mammalian atrial action potential
Christophe Simard et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Functional transient receptor potential canonical type 1 channels in human atrial myocytes
Yan-Hui Zhang et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Suppresses Experimental Arrhythmias
Luiz Belardinelli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
New directions in antiarrhythmic drug therapy for atrial fibrillation
Jordi Heijman et al.
FUTURE CARDIOLOGY (2013)
Transient Receptor Potential Canonical-3 Channel-Dependent Fibroblast Regulation in Atrial Fibrillation
Masahide Harada et al.
CIRCULATION (2012)
MK-0448, a Specific Kv1.5 Inhibitor Safety, Pharmacokinetics, and Pharmacodynamic Electrophysiology in Experimental Animal Models and Humans
Behzad B. Pavri et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)
Impact of Na+ channel blockers on transmural dispersion of refractoriness and arrhythmic susceptibility in guinea-pig left ventricle
Oleg E. Osadchii
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
A randomized trial of budiodarone in paroxysmal atrial fibrillation
Michael D. Ezekowitz et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2012)
Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial Fibrillation
Babar Parvez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Knock-Out of the Potassium Channel TASK-1 Leads to a Prolonged QT Interval and a Disturbed QRS Complex
Niels Decher et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Human Atrial Action Potential and Ca2+ Model Sinus Rhythm and Chronic Atrial Fibrillation
Eleonora Grandi et al.
CIRCULATION RESEARCH (2011)
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release
Qiang Zhou et al.
NATURE MEDICINE (2011)
New antiarrhythmic drugs for treatment of atrial fibrillation
Dobromir Dobrev et al.
LANCET (2010)
Pathophysiology and pharmacology of the cardiac late sodium current
Antonio Zaza et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Transient receptor potential channels in cardiovascular function and disease
Ryuji Inoue et al.
CIRCULATION RESEARCH (2006)
The G protein-gated potassium current IK,ACh is constitutively active in patients with chronic atrial fibrillation
D Dobrev et al.
CIRCULATION (2005)
Of circles and spirals: Bridging the gap between the leading circle and spiral wave concepts of cardiac reentry
P Comtois et al.
EUROPACE (2005)
Molecular identification and functional roles of a Ca2+-activated K+ channel in human and mouse hearts
YF Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
